HANXBIO-B (03378) has issued an announcement stating that the stabilization period relating to the global offering concluded on Saturday, January 17, 2026, which was the 30th day after the deadline for submitting Hong Kong public offering applications. Furthermore, the sponsor and overall coordinator (for itself and on behalf of the international underwriters) confirmed that there was no over-allocation of the offer shares under the international offering. Consequently, the over-allotment option was not exercised and lapsed on Saturday, January 17, 2026. The stabilization agent informed the company that neither the stabilization agent nor any person acting on its behalf undertook any stabilization actions during the stabilization period.
Comments